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Key Points Summary 
 High-fat diet consumption is a major cause of obesity. 
 Orexin neurons are known to be activated by high-fat diet and in turn promote 
further consumption of high-fat diet. 
 Our study shows that excitatory synapses to orexin neurons become amenable to 
long-term depression (LTD) after 1 week of high-fat diet feeding. However, this 
effect reverses after 4 weeks of high-fat diet. 
 This LTD may be a homeostatic response to high-fat diet to curb the activity of 
orexin neurons and hence caloric consumption. Adaptation seen after prolonged diet 
intake may contribute to development of obesity.   
 
Abstract 
Overconsumption of high-fat diets is one of the strongest contributing factors to the 
rise of obesity rates. Orexin neurons are known to be activated by palatable high-fat diet 
and mediate the activation of the mesolimbic reward pathway, resulting in further food 
intake. While short-term exposure to high-fat diet is known to induce synaptic plasticity 
within the mesolimbic pathway, it is unknown if such changes occur in orexin neurons. To 
investigate this, 3-week old male rats were fed a palatable high-fat western diet (WD) or 
control chow for 1 week and then in vitro patch clamp recording was performed. In the WD 
condition, an activity-dependent long-term depression (LTD) of excitatory synapses was 
observed in orexin neurons, but not in chow controls. This LTD was presynaptic and 
depended on postsynaptic metabotropic glutamate receptor 5 (mGluR5) and retrograde 
endocannabinoid signaling. WD also increased extracellular glutamate levels, suggesting 
that glutamate spillover and subsequent activation of perisynaptic mGluR5 may occur more 
readily in the WD condition. In support of this, pharmacological inhibition of glutamate 
uptake was sufficient to prime chow control synapses to undergo a presynaptic LTD. 
Interestingly, these WD effects are transient, as extracellular glutamate levels were similar 
to controls and LTD was no longer observed in orexin neurons after 4 weeks of WD. In 
summary, excitatory synapses to orexin neurons become amenable to LTD under palatable 
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high-fat diet, which may represent a homeostatic mechanism to prevent overactivation of 
these neurons and to curtail high-fat diet consumption. 
 
Abbreviations 
ACSF, artificial cerebrospinal fluid; AM251, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-
methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide; CB1R, type 1 cannabinoid receptor; 
Ctrl, control; CPPG, (RS)-α-cyclopropyl-4-phosphonophenylglycine; DAP5, D-2-amino-5-
phosophonovalerate; DHK, dihydrokainic acid; DHPG, (S)-3,5-dihydroxyphenylglycine; 
γDGG, γ-D-glutamylglycine; GLAST, glutamate-aspartate transporter; GLT-1, glutamate 
transporter-1; HFS, high-frequency stimulation; LTD, long-term depression; LTP, long-
term potentiation; mGluR, metabotropic glutamate receptor; MPEP, 6-methyl-2-
(phenylethynyl)pyridine; PPR, paired pulse ratio; VTA, ventral tegmental area; WD, 
western diet  
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Introduction 
Excessive consumption of high-fat diets has become increasingly common in many 
countries around the world, increasing the risks of serious health outcomes such as 
cardiovascular diseases, metabolic syndrome, and obesity (Cordain et al., 2005). Caloric 
consumption beyond metabolic need is driven by the rewarding value of high-fat food, 
which is mediated by the mesolimbic dopamine pathway (Volkow et al., 2011). Activation 
of this pathway by high-fat diet involves orexin signaling. Specifically, orexin neurons are 
activated by short-term high-fat diet (Chang et al., 2004; Valdivia et al., 2014) and 
subsequently stimulate dopamine neurons within the ventral tegmental area (VTA), thereby 
activating the mesolimbic pathway (Zheng et al., 2007; Valdivia et al., 2014; Baimel et al., 
2017). This suggests that a positive feedback loop between high-fat diet, orexin neurons 
and VTA dopamine neurons drives overconsumption of high-fat diet. However, high-fat 
diet may suppress the orexin system in the long term, as chronic high-fat diet decreases 
orexin gene and peptide levels in animals (Novak et al., 2010; Tanno et al., 2013). Thus, 
the regulation of the orexin system may change over the course of high-fat diet feeding.  
While high-fat diet is known to induce various types of functional and structural 
plasticity within the reward circuitry (Johnson & Kenny, 2010; Vucetic et al., 2012; 
Sharma et al., 2013; Labouèbe et al., 2013), plastic changes in orexin neurons during high-
fat diet are poorly understood. There has been one study that investigated synaptic plasticity 
in orexin neurons after chronic high-fat diet, which found changes in type 1 cannabinoid 
receptor (CB1R)-expressing presynaptic terminals apposed to orexin neurons (Cristino et 
al., 2013). However, to our knowledge there has been no report on the effect of short-term 
high fat diet on synaptic plasticity of these neurons. Plasticity of excitatory synapses should 
impact the excitability of orexin neurons, as excitatory synaptic contacts to these neurons 
significantly outnumber inhibitory ones and influence their basal firing rate (Li et al., 2002; 
Horvath & Gao, 2005). Moreover, orexin neurons are known to display plasticity of 
excitatory synapses under various physiological states, such as fasting (Horvath & Gao, 
2005) and sleep deprivation (Rao et al., 2007), which has been postulated to affect foraging 
and arousal, respectively.   
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In this study, we investigated the effect of short-term exposure to a palatable high-
fat western diet (WD) on excitatory transmission to orexin neurons. We identified a novel 
form of long-term plasticity of these synapses after one week of WD feeding, which was 
diminished after a prolonged WD exposure. These changes may alter orexin network 
properties and underlie their physiological role in reward-based feeding during short- and 
long-term high-fat diet. 
 
Methods 
Ethical Approval 
All animal procedures were conducted as approved by the Memorial University’s 
Institutional Animal Care Committee under the guidelines of the Canadian Council on 
Animal Care.  
Animals and Diets 
Male 3-week old Sprague-Dawley rats were obtained either from Charles River 
(Quebec, Canada) or Memorial University’s Breeding Colony. Upon arrival, rats were 
singly housed and given either WD (TestDiet AIN-76A: 4.55kcal/g, 40% fat, 16% protein, 
and 44% carbohydrates by caloric content) or a standard rodent chow (LabDiet 5010: 
3.08kcal/g, 12.7% fat, 28.7% protein, and 58.5% carbohydrates). Body weight and food intake 
were measured weekly. A total of 90 rats were used in this study. 
Electrophysiological Recording 
After 1 or 4 weeks of feeding, rats were anesthetized with isoflurane inhalation and 
sacrificed by decapitation. The brain was removed and acute 250-µm hypothalamic slices 
were generated on a vibratome (VT-1000, Leica Microsystems) in artificial cerebrospinal 
fluid (ACSF) composed of 126mM NaCl, 2.5mM KCl, 1.2mM NaH2PO4, 1.2mM MgCl2, 
18mM NaHCO3, 2.5mM glucose, and 2mM CaCl2. ACSF was chilled on ice for 5-10 
minutes before slicing. After dissection, hypothalamic slices were incubated at 32-34 ̊C for 
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30-35 minutes in ACSF then left at room temperature until experiments were performed. 
ACSF was continuously bubbled with 95% O2/5% CO2 gas.  
Slices were transferred to a recording chamber, perfused with ACSF (1-2mL per 
minute at 30-32 ̊C) and visualized with infrared-differential interference contrast optics 
(DM LFSA, Leica Microsystems). Whole-cell patch clamp recordings were performed on 
neurons within the lateral hypothalamus/perifornical area using Multiclamp 700B and 
pClamp 9 or 10 software (Molecular Devices, Sunnyvale, CA, US). Signals were filtered at 
1kHz and digitized at 5-10kHz. An internal solution containing 123mM K gluconate, 2mM 
MgCl2, 1mM KCl, 0.2mM EGTA, 10mM HEPES, 5mM Na2ATP, 0.3mM NaGTP, and 
2.7mM biocytin was used to fill glass patch electrodes with a final tip resistance between 3-
5MΩ.  
Afferent fibers were electrically stimulated via a glass pipette filled with ACSF 
placed medial to recorded neurons, using a voltage that results in approximately 50% of 
maximum synaptic response. Evoked EPSCs were pharmacologically isolated using the 
GABAA channel blocker picrotoxin (50µM) and recorded every 15 seconds at a holding 
potential of –70mV. These EPSCs are largely mediated by AMPA receptors but not kainite 
receptors (Alberto & Hirasawa, 2010). Paired pulses were applied at 10 or 50Hz to assess 
paired pulse ratio (PPR) defined as the amplitude of EPSC2 divided by that of EPSC1. To 
induce activity-dependent synaptic plasticity, a high frequency stimulation (HFS) was 
applied to the afferents using the same stimulation electrode while in current clamp mode, 
consisting of 100 pulses at 100Hz every 4 seconds, 10 times. Long-term synaptic plasticity 
was assessed at 25-30 minutes post-HFS or at 25-30 minutes following the start of DHPG 
application. Series/access resistance was assessed by applying 20mV, 50ms 
hyperpolarizing pulses every 15 seconds. Cells that showed a change in these parameters by 
more than 20% were excluded from further analysis.   
Identification of Orexin Neurons 
A series of 600-ms hyperpolarizing and depolarizing current steps were applied in 
current clamp mode to identify putative orexin neurons. Orexin neurons display a distinct 
electrophysiological response to this current protocol compared to other cell types in the 
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region which allow for high accuracy cell-type identification (Alberto et al., 2011; Linehan 
et al., 2015). Specifically, orexin neurons display spontaneous firing, uniphasic 
afterhyperpolarizing potential, H-current, and rebound depolarization following relief from 
hyperpolarization.  
To confirm the neurochemical phenotype, post hoc immunohistochemistry was 
performed in a subset of cells (116 of 175 cells). During recording, cells were filled with 
biocytin via the recording pipette and subsequently brain slices were fixed in 10% formalin 
for at least 24 hours. Slices were then incubated with a goat anti-orexin A IgG (1:2000; 
SC8070, Santa Cruz Biotechnology, Santa Cruz, CA) for 3 days, followed by Alexa 594-
conjugated donkey anti-goat IgG (1:500) and Alexa 350-conjugated streptavidin (1:500). 
Colocalization of biocytin with orexin A staining was assessed on an epifluorescence 
microscope. Electrophysiologically-identified orexin neurons were correctly confirmed by 
immunohistochemistry in 115 of 116 cells tested (99.1% success rate), and the one 
immuno-negative cell was removed. A total of 174 cells that displayed the characteristic 
electrophysiological fingerprint of orexin neurons were used in the analysis. 
Drugs 
Drugs were prepared as stock solutions and were diluted with ACSF to the final 
concentration immediately prior to experiment except for GDPβS, which was added to the 
internal solution at its final concentration (2mM) in place of GTP. DAP5, MPEP, AM251, 
CPPG and DHK were bath applied for 10 minutes before HFS up until 5 minutes post-HFS, 
unless indicated otherwise. DHPG and DGG were bath applied for 5 minutes. Picrotoxin, 
GDPβS, and AM251 (1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-
1H-pyrazole-3-carboxamide) were from Sigma Aldrich (Oakville, ON, CA); DAP5 and γ-
D-glutamylglycine (γDGG) were from Abcam (Cambridge, MA, US); and 6-methyl-2-
(phenylethynyl)pyridine (MPEP), dihydrokainic acid (DHK), (RS)-α-cyclopropyl-4-
phosphonophenylglycine (CPPG), and (S)-3,5-dihydroxyphenylglycine (DHPG) were from 
Tocris Bioscience (Minneapolis, MN, US). 
Statistical Analysis 
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The number of samples is reported in the nested model where N/n represents the 
number of cells/ the number of animals. Data are expressed as the mean ± SEM and p<0.05 
was considered significant. Statistical analyses were performed using Prism 6.0 (GraphPad 
Software Inc.). Unpaired or paired t-test and one-way or two-way ANOVA with post hoc 
Holm-Sidak test were performed on the data as applicable.  
 
Results 
To examine the effects of high-fat diet on orexin neurons, rats were fed with either a 
WD or a standard chow (Ctrl) for up to 4 weeks. Rats on WD consistently consumed more 
calories throughout the feeding period compared to chow controls (Fig.1A,C; Ctrl n=20 rats 
vs WD n=22 rats; weekly caloric intake, two-way ANOVA: F1,40=34.16, p<0.0001; total 
caloric intake, unpaired t-test: t40=5.845, p<0.0001); however, this did not result in any 
difference in body weight at any time point (Fig.1B; two-way ANOVA: F1,40=1.020, 
p=0.3185). At the end of the 4-week feeding, there was no difference in body weight (Fig. 
1D; unpaired t-test: t40=1.488, p=0.1446) or total weight gain between groups (Fig. 1E; 
unpaired t-test: t40=1.702, p=0.0966). Following the feeding period, patch clamp recordings 
were performed on orexin neurons at two time points: after 1 week of feeding when these 
neurons are known to be activated by high-fat diet (Wortley et al., 2003; Valdivia et al., 
2014), and at 4 weeks, when orexin gene expression has been shown to first decrease 
(Novak et al., 2010). 
After 1 week of feeding, all orexin neurons tested in the WD condition displayed a 
long-term depression (LTD), resulting in approximately a 50% reduction on average in 
EPSC amplitude (Fig.2A-C; n=6/4, baseline vs post-HFS, paired t-test: t5=2.815, 
p=0.0373). In contrast, chow control orexin neurons did not display a consistent response. 
A fraction of cells (2 out of 7 cells) displayed a long-term potentiation (LTP), defined as an 
increase in EPSC amplitude by more than 20% of baseline values, while others showed no 
change (Fig.2A-C; n=7/4, baseline vs post-HFS, paired t-test: t6=1.079, p=0.3218). 
Collectively, EPSC amplitude post-HFS was significantly different between chow control 
and WD (Fig.2C; unpaired t-test: t11=3.933, p=0.0023). The LTD in the WD group was 
9 
 
accompanied by an increase in PPR (Fig.2A,D; baseline vs post-HFS, paired t-test: 
t5=6.250, p=0.0015) but there was no PPR change in chow controls (Fig.2D; baseline vs 
post-HFS, paired t-test: t6=0.1598, p=0.8783; Ctrl vs WD, unpaired t-test: t11=2.335, 
p=0.0395). Thus, LTD in the WD condition has a presynaptic locus of expression. 
Since WD unmasked a robust LTD in orexin neurons, we sought to determine the 
mechanism underlying this plasticity using brain slices from WD-fed rats. NMDA receptors 
are commonly involved in long-term synaptic plasticity, however, the NMDA receptor 
antagonist DAP5 (50µM) failed to significantly influence the HFS-induced changes in 
EPSC amplitude (Fig.3A,C; HFS n=6/4 vs. HFS+DAP5 n=8/5, one-way ANOVA,  
t16=0.9014, p=0.3807) or PPR (Fig.3D; HFS vs HFS+DAP5, one-way ANOVA, t16=1.901, 
p=0.0755). Another glutamate receptor that could mediate presynaptic LTD is metabotropic 
glutamate receptor 5 (mGluR5) (Robbe et al., 2002). We found that LTD was attenuated by 
the mGluR5-specific antagonist, MPEP (20-40µM) (Fig.3B-D; EPSC amplitude: HFS 
n=6/4 vs HFS+ MPEP n=5/4, one-way ANOVA, t16=3.447, p=0.0066; PPR: HFS vs 
HFS+MPEP, one-way ANOVA, t16=3.878, p=0.0027). Further supporting an mGluR5 
involvement, the group 1 mGluR agonist DHPG (50µM) induced a presynaptic LTD on its 
own (Fig.3E,F; n=13/7, paired t-test: EPSC amplitude t12=9.158, p<0.0001; PPR t12 =2.771, 
p=0.0169) and occluded HFS-induced LTD (Fig.3E,G-I; HFS n=6/4 vs HFS post-DHPG 
n=6/3, unpaired t-test: EPSC amplitude t10=4.212, p=0.0018; PPR t10=3.855, p=0.0032). 
Taken together, these results suggest that LTD unmasked by WD is due to an mGluR5-
dependent mechanism. 
To test the role of postsynaptic cell in LTD, 2mM GDPβS was added to the pipette 
solution and allowed to diffuse into the cell for 10 minutes prior to baseline recording. We 
have shown previously that this concentration of GDPβS and procedure inhibits G protein 
signaling within orexin neurons (Parsons et al., 2012). We found that GDPβS blocked both 
the WD-induced reduction in EPSC amplitude (Fig.4A-C; HFS n=6/4 vs HFS+GDPβS 
n=6/5, unpaired t-test, t10=2.865, p=0.0168) and the increase in PPR (Fig.4C; HFS vs 
HFS+GDPβS, unpaired t-test, t10=4.271, p=0.0016). These data indicates that postsynaptic 
G protein signaling is required, which supports mGluR5 involvement. Since this LTD is 
presynaptic, this result suggests a retrograde transmitter such as endocannabinoids must be 
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involved (Robbe et al., 2002). Consistent with this idea, the CB1R antagonist AM251 
(5µM) blocked HFS-induced LTD (Fig.4D,F; EPSC amplitude: HFS n=6/4 vs 
AM251+HFS n=5/4, one-way ANOVA, t14=2.985, p=0.0196; PPR: HFS vs AM251+HFS, 
one-way ANOVA, t14=2.020, p=0.1220). However, endocannabinoid signaling is only 
important for the induction of LTD as AM251 had no effect on the maintenance of LTD 
when applied 20-30 minutes after HFS (Fig.4E,F; EPSC amplitude: HFS n=6/4 vs 
HFS+AM251 n=6/3, one-way ANOVA,  t14=0.5330, p=0.6024; PPR: HFS vs. 
HFS+AM251, one-way ANOVA, t14=0.6448, p=0.5295). Furthermore, DHPG was unable 
to induce LTD in the presence of AM251, indicating that CB1R is downstream of mGluR5 
(Fig.4G,I; EPSC amplitude: DHPG n=13/7 vs AM251+DHPG n=6/3, one-way ANOVA, 
t23=2.679, p=0.0266; PPR: DHPG vs AM251+DHPG, one-way ANOVA, t23=3.699, 
p=0.0024). Similar to the HFS-induced LTD, AM251 applied 15 minutes following DHPG 
wash did not affect DHPG-LTD (Fig.4H, I; EPSC amplitude: DHPG vs DHPG+AM251 
n=7/4, one-way ANOVA, t23=1.478, p=0.1531; PPR: DHPG vs DHPG+AM251, one-way 
ANOVA, t23=0.1855, p=0.8544). These results indicate that LTD in orexin neurons is 
dependent on postsynaptic mGluR5 and retrograde endocannabinoid signaling.  
It remains unknown why LTD is consistently observed in orexin neurons in the WD 
condition but not in chow-fed controls. One possibility is that orexin neurons do not 
express functional mGluR5 receptors in chow conditions. However, pharmacologically 
activating group 1 mGluRs in chow controls using the group 1-specific mGluR agonist 
DHPG also led to a presynaptic LTD (Fig.5A-D; ESPC amplitude, n=7/5: baseline vs post-
DHPG, paired t-test: t6=4.421, p=0.0045; PPR: baseline vs post-DHPG, paired t-test: 
t6=2.973, p=0.0249). Thus, the molecular machinery necessary for mGluR5-dependent 
LTD is intact even in chow-fed condition. 
Interestingly, the magnitude of DHPG-induced LTD was smaller in WD (Fig.5B,C; 
Ctrl n=7/5 vs WD n=13/7, unpaired t-test: t18=2.217, p=0.0397), which may be an 
indication that endogenously established LTD was occluding the effect of DHPG. If so, 
presynaptic glutamate release would be inhibited, which should be observed as an increase 
in PPR. This indeed appeared to be the case since the baseline PPR was higher in the WD 
group compared to chow controls (Fig.6A,B; Ctrl n=21/14 vs WD n=17/10, unpaired t-test: 
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t35=2.615, p=0.0131). An alternative explanation for this higher PPR is a tonic activation of 
presynaptic inhibitory group III mGluRs (Acuna-Goycolea et al., 2004); however, the 
group III mGluR antagonist CPPG (200µM) had no effect on EPSCs in the WD condition 
(Fig.6C; ESPC amplitude, n=6/3: baseline vs CPPG, paired t-test: t5=0.6686, p=0.5333; 
PPR: baseline vs CPPG, paired t-test: t5=0.7826, p=0.4693). These results suggest that LTD 
may have occurred endogenously in orexin neurons in the WD condition and partially 
occluded the effects of DHPG.  
Since the signaling components for group 1 mGluR-dependent LTD are present in 
both chow and WD conditions, unmasking of HFS-LTD by WD may involve a process 
upstream of mGluR5 activation, such as synaptic glutamate clearance. To detect any 
difference in the level of extracellular glutamate during synaptic activity, we used the low 
affinity, competitive AMPA receptor antagonist γDGG, which competes with endogenous 
glutamate for AMPA receptors. We determined that 1mM γDGG reduced EPSC amplitude 
by about 50% at these synapses in chow controls (Liu et al., 1999) (Fig.7A,B; n=7/3: 
baseline vs γDGG, paired t-test: t6=4.771, p=0.0031) and used this concentration to test the 
diet effect. In the WD group, it induced significantly less inhibition of EPSCs (Fig.7A,B; 
n=7/4: baseline vs γDGG, paired t-test: t6=5.449, p=0.0016; Ctrl vs WD, unpaired t-test: 
t12=3.443, p=0.0049). These results indicate that WD induces an increase in extracellular 
glutamate. However, there was no difference in the decay of EPSCs between WD and chow 
controls (Fig.7C,D; EPSC decay: Ctrl n=13/8 vs WD n=10/6, unpaired t-test: t21=0.04987, 
p=0.9607), suggesting that the time course of the glutamate transient at the synapse is not 
affected. 
An increase in synaptic glutamate may lead to more glutamate spillover during HFS 
to activate perisynaptic mGluR5 receptors and their downstream LTD signaling cascade. 
To test this idea, we used DHK, an inhibitor of the astrocytic glutamate transporter-1 (GLT-
1), to inhibit glutamate uptake and facilitate spillover in chow controls. A submaximal 
concentration of DHK (10-15µM) was used to avoid excitotoxicity, which did not affect 
EPSC amplitude (n=8/4, baseline: 302.2 ± 70.1pA, DHK: 276.9 ± 73.3pA, paired t-test: 
t7=1.264, p=0.2466) or decay (Fig.7E; paired t-test: t7=0.5208, p=0.6186). However, in the 
presence of DHK, chow control synapses expressed a presynaptic LTD in response to HFS 
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(Fig. 7F-H; DHK+HFS n=6/3, baseline vs post-HFS: EPSC amplitude, paired t-test: 
t5=2.928, p=0.0327; PPR, paired t-test: t5=2.641, p=0.0459) unlike untreated controls (Ctrl 
EPSC amplitude: untreated n=7/4 vs DHK n=6/3, two-way ANOVA, t21=3.843, p=0.0019; 
Ctrl PPR: untreated vs DHK, two-way ANOVA, t21=2.539, p=0.0378). In contrast, in the 
WD condition DHK had no additive effect on the magnitude of LTD (Fig.7G,H; WD EPSC 
amplitude: untreated n=6/4 vs DHK n=6/3, two-way ANOVA, t21=0.5127, p=0.6135; WD 
PPR: untreated vs DHK, two-way ANOVA, t21=1.952, p=0.0644). Thus, WD occludes 
DHK’s priming effect, further supporting a role for increased extracellular glutamate in 
LTD induction.  
Finally, we asked whether these WD-induced synaptic changes are long lasting. 
After 4 weeks of feeding, we found that there was no longer any difference between WD 
and age-matched chow control groups in extracellular glutamate as measured by the degree 
of EPSC inhibition by γDGG (Fig.8A,B; 4wCtrl n=8/7 vs 4wWD n=7/6, unpaired t-test: 
t13=0.4027, p=0.6937). Accordingly, neither group expressed HFS-induced LTD (Fig.8C-E; 
4wCtrl n=7/3 vs 4wWD n=7/4, EPSC amplitude: unpaired t-test: t12=0.4771, p=0.6418, 
PPR: unpaired t-test: t12=0.3425, p=0.7379). Therefore, adaptation to WD occurs at 
excitatory synapses to orexin neurons. 
 
Discussion 
The present study demonstrates that one week of WD feeding primes excitatory 
synapses to orexin neurons to undergo activity-dependent LTD. WD increases the level of 
synaptic glutamate, which results in activation of postsynaptic mGluR5 during intense 
synaptic activity. This leads to endocannabinoid-mediated presynaptic LTD (Fig.9). This 
priming effect is transient and disappears with longer periods of WD feeding. To our 
knowledge, this is the first study to describe LTD of excitatory inputs to orexin neurons. 
Orexin neurons have been shown to synthesize and release endocannabinoids in response to 
membrane depolarization (Cristino et al., 2013), which in turn acutely inhibit excitatory 
and inhibitory transmission (Huang et al., 2007; Cristino et al., 2013). Our results show that 
mGluR5 can also trigger endocannabinoid release from orexin neurons that retrogradely 
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induces an LTD of excitatory synapses. On the other hand, a previous study described a 
postsynaptic LTP at these synapses via a cAMP-dependent mechanism (Rao et al., 2007). 
In our chow controls, HFS induced LTP without a change in PPR in 28.6% of cells tested, 
which may be explained by the mechanism described above.  
While the source of excitatory afferents to orexin neurons tested in this study were 
not defined, these neurons are known to receive inputs from diverse brain regions involved 
in energy balance, reward, and sleep/wake control (González et al., 2016). In addition, 
orexin neurons have wide-ranging projections to brain regions involved in these functions 
(Peyron et al., 1998). Since LTD was observed in all WD orexin neurons tested, it may not 
be a mechanism restricted to certain afferent or efferent pathways, but rather it may be a 
general property that could influence synaptic integration and functional output of these 
neurons, including arousal, energy balance, motivation, locomotor activity, and sympathetic 
outflow (Tsujino & Sakurai, 2013). 
Although WD feeding was necessary for HFS to induce LTD, pharmacological 
activation of group 1 mGluRs could induce LTD in both Ctrl and WD conditions. 
Therefore, the machinery for the mGluR5-CB1R LTD is present and functional under both 
conditions. Nevertheless, the magnitude of DHPG-induced LTD was smaller in WD 
compared to chow controls, which may be a partial occlusion by endogenous LTD in WD-
fed rats. This is supported by a higher baseline PPR in WD cells suggesting an underlying 
presynaptic inhibition. Alternatively, a change in cell surface expression (Knackstedt & 
Schwendt, 2016) or perisynaptic localization of mGluR5 receptors (Sergé et al., 2002) may 
account for this difference. In addition, chronic high-fat diet has been shown to decrease the 
number of CB1R-expressing excitatory synapses to orexin neurons (Cristino et al., 2013), 
which could influence this CB1R-dependent LTD. However, whether this type of synaptic 
remodeling would occur after 1 week of WD feeding is unknown. 
Our study suggests that a change in extracellular glutamate levels underlies the WD-
induced unmasking of LTD in orexin neurons. Extracellular glutamate concentration can be 
influenced by the amount of release, uptake, and diffusion. It is unlikely that WD increases 
glutamate release, as our results showing an increase in baseline PPR indicate reduced 
14 
 
release. Altered glutamate diffusion can result from a change in synaptic morphology (Piet 
et al., 2004), which may accompany synaptic remodeling known to be induced by dietary 
factors in orexin neurons (Horvath & Gao, 2005; Cristino et al., 2013). Extracellular 
glutamate could also increase if glutamate uptake through transporter activity is decreased. 
Indeed, hormones influenced by high-fat diet, such as leptin and ghrelin, modulate the 
expression of astrocytic glutamate transporters GLT-1 and GLAST in the hypothalamus 
(Fuente-Martín et al., 2012, 2016). Furthermore, we showed that a GLT-1 inhibitor DHK 
mimics WD and permits HFS-induced LTD in chow control orexin neurons. Thus, a 
decrease in glutamate transport may be at least partially responsible for increased 
extracellular glutamate by WD.  
The effects of high-fat diet on the orexin system are known to be time-dependent: 
short exposures to high-fat diet stimulate, while longer exposures suppress the orexin 
system. For example, after 2 hours of high-fat diet, orexin neurons increase cFos expression 
(Valdivia et al., 2014) while cell density and mRNA expression increases within 3 weeks of 
high-fat diet (Wortley et al., 2003, but see Ziotopoulou et al., 2000). Since orexin is 
necessary for  high-fat diet-induced activation of the VTA (Zheng et al., 2007; Valdivia et 
al., 2014), plasticity at the level of orexin neurons could have functional consequences 
within the reward circuitry. Moreover, high-fat diet also induces an endocannabinoid-
dependent LTD in the VTA and decreases the salience of high-fat diet (Labouèbe et al., 
2013). Therefore, LTD at both sites could act in concert to regulate behavioral responses to 
high-fat diet. 
In contrast to these short-term excitatory effects, prolonged exposures (1 to 4 
months) reduce orexin gene and peptide levels (Novak et al., 2010; Tanno et al., 2013). In 
keeping with this, the present study found that LTD was no longer induced after 4 weeks of 
WD. This adaptation to long-term WD is unlikely to be secondary to weight gain, since in 
the present study there was no detectable difference in body weight gain of the rats between 
diet groups for up to 4 weeks of feeding. On the other hand, the animals on WD 
consistently consumed more calories in fat, therefore the observed synaptic changes may be 
secondary to an extended presence of triglycerides or dynamic changes in diet-sensitive 
hormone levels that have time-dependent effects on the brain and behavior (Fuente-Martín 
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et al., 2012, 2016; Cansell et al., 2014). Alternatively, it may be due to the age of animals, 
since the developing brain is more vulnerable than adults to the effects of high-fat diet 
(Morin et al., 2017). Furthermore, the expression of astrocytic glutamate transporters 
rapidly increases postnatally and continues to increase into adulthood (Furuta et al., 1997). 
The hypothalamic energy balance circuitry also continues to develop postnatally (Bouret et 
al., 2004) including orexin neurons (Ogawa et al., 2017). Therefore, it is possible that in 
young animals, such as those used in this study (3 weeks of age at the start of feeding 
paradigm), orexin neurons are particularly sensitive to diet-induced plasticity.  
In summary, the present study demonstrates a novel mechanism by which WD 
induces time-dependent metaplasticity in orexin neurons. In a recent paper using a similar 
WD and animal model as our study, adolescent male Sprague-Dawley rats were shown to 
display reward hypofunction after 10 days of WD that was normalized by continued WD 
feeding into adulthood (Rabasa et al., 2016). It is tempting to speculate that priming of 
orexin neurons to LTD and its reversibility shown in our study contributes to these 
behavioral response and adaptation to WD. Furthermore, in addition to food intake this 
synaptic plasticity may also underlie alterations in other physiological functions associated 
with high-fat diet and obesity, such as diminished wakefulness/alertness and energy 
expenditure that can be explained by inhibition of orexin neurons (Jenkins et al., 2006; 
Tanno et al., 2013).   
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Figure 1: Caloric intake and body weight of rats during WD feeding. 
A) Weekly caloric intake of rats fed with control chow (Ctrl) or WD. 
B) Body weight of rats during the 4-week feeding period. 
C) Total caloric intake during the 4-week feeding period. 
D) Body weight of rats after 4-week feeding (7-week old). 
E) Total body weight gain during the 4-week feeding period. 
***p<0.0005, ****p<0.0001 
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Figure 2: One-week WD primes orexin neurons for HFS-induced presynaptic LTD.  
A) Sample traces showing paired EPSCs of orexin neurons in Ctrl and WD groups at 
baseline (a) and post-HFS (b), recorded at time points indicated in panel B. Post-
HFS traces are scaled so that the first EPSC of baseline and post-HFS are 
comparable. Dotted reference lines show that the paired pulse ratio (PPR) changed 
in WD but not in Ctrl. 
B) EPSC amplitude normalized to respective baseline in WD and Ctrl orexin neurons. 
HFS was applied at time 0. 
C) EPSC amplitude post-HFS (b in panel B) normalized to a 5-minute baseline (a in 
panel B). For C and D, each symbol denotes an individual orexin neuron. 
D) PPR post-HFS as a percent of baseline in the Ctrl and WD groups. 
*p<0.05, **p<0.005 Ctrl vs WD; #p<0.05, ##p<0.005 baseline vs post-HFS 
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Figure 3: LTD unmasked by WD is mGluR5-dependent. 
A) Top: Sample EPSCs (top) and time-effect plot of EPSC amplitude (bottom) from a 
WD orexin neuron showing the effect of HFS in the presence of DAP5 (50µM).  
B) Sample EPSCs (top) and time-effect plot of EPSC amplitude (bottom) pre- and 
post-HFS in the presence of group 1 mGluR antagonist MPEP (20-40µM).  
C and D) Summary of EPSC amplitude (C) and PPR (D) post-HFS normalized to 
baseline. HFS-induced LTD is not affected by DAP5 but blocked by MPEP. 
E) Representative time effect plot of DHPG (50µM) application and subsequent HFS 
on EPSC amplitude in a WD orexin neuron. 
F) EPSC amplitude and PPR post- DHPG application. 
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G) EPSC amplitude from the experiment shown in E, normalized to pre-HFS values. 
Following DHPG application, HFS has no effect on EPSC amplitude. 
H and I) Summary of EPSC amplitude (H) and PPR (I) post-HFS normalized to 
respective baseline without or with prior DHPG application. DHPG occludes HFD-
induced LTD in WD orexin neurons. 
**p<0.01 for comparisons of different experimental groups; #p<0.05, ##p<0.005, 
####p<0.0001 baseline vs post-treatment 
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Figure 4: LTD is mediated by retrograde endocannabinoid signaling in orexin 
neurons. 
A) Sample EPSCs recorded from a WD orexin neuron with an inhibitor of G-protein 
signaling GDPβS (2mM) in the recording pipette.  
B) Time-effect plot of EPSC amplitude recorded with GDPβS in the recording pipette.  
C) Summary of experiments shown in B. HFS has no effect on EPSC amplitude or 
PPR when applied in the presence of GDPβS. 
D) Sample ESPCs from a WD orexin neuron (top) and time-effect plot of EPSC 
amplitude (bottom) recorded before and after HFS, applied in the presence of the 
CB1R antagonist AM251 (AM; 5µM).   
E) Sample recording from a WD orexin neuron (top) and time-effect plot of EPSC 
amplitude (bottom) showing that HFS–induced LTD is not affected by AM251 
applied 20-30 minutes after HFS. 
F) Summary of experiments shown in D and E. Normalized EPSC amplitude (top) and 
PPR (bottom) at 25-30 minutes post-HFS in orexin neurons. AM251 prevents LTD 
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when present during HFS (AM+HFS), but not when applied after LTD is 
established (HFS+AM). 
G) Sample ESPCs from a WD orexin neuron (top) and time-effect plot of EPSC 
amplitude (bottom) showing lack of effect of DHPG when applied in the presence 
of AM251.  
H) Sample ESPCs from a WD orexin neuron (top) and time-effect plot of EPSC 
amplitude (bottom) showing that AM251 has no effect on DHPG-induced LTD. 
I)  Summary of experiments shown in G and H, showing normalized EPSC amplitude 
(top) and PPR (bottom) post-DHPG. AM251 prevents DHPG-induced LTD when 
applied concurrently with DHPG (AM+DHPG), but it is unable to reverse LTD 
after it is established (DHPG+AM). 
*p<0.05, **p<0.01, for comparisons of different experimental groups  
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Figure 5: Group 1 mGluR activation induces presynaptic LTD regardless of diet. 
A) Sample EPSCs recorded from Ctrl or WD orexin neuron during baseline or 25-30 
minutes after DHPG (50µM) application.  
B) Time-effect plot of EPSC amplitude with application of DHPG.  
C and D) EPSC amplitude (C) and PPR (D) following DHPG application. DHPG 
induces LTD in both Ctrl and WD conditions, however the magnitude of LTD is 
greater in Ctrl. 
*p<0.05 Ctrl vs WD; #p<0.05, ##p<0.01, ####p<0.0001 baseline vs post-DHPG 
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Figure 6: WD induces presynaptic inhibition independent of group III mGluR. 
A) Sample traces of paired EPSCs recorded from orexin neurons in Ctrl and WD 
conditions. 
B) WD increases baseline PPR in orexin neurons. 
C) Group III mGluR antagonist CPPG (200µM) has no effect on EPSC amplitude or 
PPR in WD orexin neurons. 
*p<0.05  
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Figure 7: Reduced synaptic glutamate clearance may underlie the unmasking of LTD 
by WD. 
A) Sample EPSCs showing the effect of the low-affinity, competitive AMPA receptor 
antagonist γDGG (1mM) on EPSC amplitude in orexin neurons. 
B) EPSC amplitude is less sensitive to the inhibitory effect of γDGG in WD than in 
Ctrl. 
C) Sample EPSCs (without drug or HFS treatment) and their overlay showing similar 
decay times in Ctrl and WD conditions. 
D) Diet has no effect on the 10-90% decay time of AMPA receptor-dependent EPSCs. 
E) GLT-1 inhibitor DHK (10-15µM) has no effect on the 10-90% decay time of 
AMPA receptor-dependent EPSCs.  
F) Time-effect plot showing that HFS induces LTD in the presence of DHK in the 
chow Ctrl condition. 
G and H) Normalized ESPC amplitude (G) and PPR (H) post-HFS in Ctrl or WD orexin 
cells. HFS was applied in the absence (untreated; black circle) or presence of DHK 
(gray circle). LTD is primed by DHK in Ctrl but not WD condition.  
31 
 
*p<0.05, **p<0.01 comparing between experimental groups; #p<0.05, ### p<0.001 
baseline vs post-HFS; ##p<0.005 baseline vs. γDGG. 
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Figure 8: Prolonged WD feeding reverses synaptic priming for LTD in orexin 
neurons. 
A) Sample EPSCs before and during γDGG (1mM) application in orexin neurons from 
rats fed WD for 4 weeks (4wWD) and age-matched controls (4wCtrl). 
B) Inhibitory effect of γDGG on EPSC amplitude is not different between 4wWD and 
4wCtrl. 
C) Time-effect plot of HFS on EPSC amplitude showing a lack of HFS effect in orexin 
neurons from 4wCtrl or 4wWD groups.  
D and E) EPSC amplitude (D) and PPR (E) are not affected by HFS after 4 weeks of 
control chow or WD. 
##p<0.01, ### p<0.001 baseline vs. γDGG. 
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Figure 9: Proposed mechanism of LTD in orexin neurons. 
A) In chow-fed condition (Ctrl), synaptically released glutamate is efficiently removed 
by transporters such as GLT-1, preventing perisynaptic mGluR5 activation.  
B) In WD-fed condition, synaptic glutamate is not efficiently cleared and spills over 
during high intensity synaptic activity. This activates mGluR5 and subsequent 
retrograde endocannabinoid (eCB) signaling to CB1R-expressing excitatory 
synaptic terminals, resulting in presynaptic LTD.  
